Patent portfolio secures innovation for the future of heart replacement - TUCSON, Ariz., Sept. 22, 2025 (GLOBE NEWSWIRE) -- ...

Picard Medical (NYSE:PMI) announced today that it expanded its IP portfolio with a new U.S. patent for its next-generation ...

Strong commercial momentum driven by higher product sales – Total revenue and $19.5 million IPO proceeds support expansion ...

Picard Medical (PMI) announced the strengthening of its intellectual property portfolio with the recent grant of U.S. Patent No. 12,383,722 B2 ...

Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.

TUCSON, Ariz., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (PMI) (“Picard” or the “Company”), a medical technology company that manufactures and sells the only total artificial heart (the ...

Picard Medical, Inc. (NYSE American: PMI) ('Picard” or the 'Company”), today announced that Patrick NJ Schnegelsberg, Chief Executive Officer, will present in-person at the H.C. Wainwright 27th Annual ...

An update from Picard Medical, Inc. ( ($PMI) ) is now available. Picard Medical, Inc. announced on September 9, 2025, that it ...

Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that the underwriters of its previously announced initial public offering of common stock, par value $0.0001 per ...

Picard Medical, Inc. (NYSE American: PMI) announced that underwriters of its initial public offering exercised their over-allotment option in full on September 5, 2025, according to a company ...

A Tucson-based company that makes the only federally approved temporary artificial human heart in the U.S. and Canada raised more than $17 million in its stock market ...

A tiny camera coupled with AI technology can accurately predict the risk of a second heart attack, according to new research. The miniature camera takes measurements inside the patient's coronary ...